The mark consists of "BREYANZI" in dark blue font with an orange dot over the "I" with a sunburst design behind and above the "ZI" with half of the dots in the upper side in dark blue dots and the other half of the dots in the lower side in light blue dots.
Mark For: BREYANZI® trademark registration is intended to cover the categories of
>The color(s) dark blue, light blue, and orange is/are claimed as a feature of the mark. The mark consists of "BREYANZI" in dark blue font with an orange dot over the "I" with a sunburst design behind and above the "ZI" with half of the dots in the upper side in dark blue dots and the other half of the dots in the lower side in light blue dots.
Research | OneLook Acronym Finder |
Serial Number | 88569196 |
Registration Number | 6834335 |
Mark Literal Elements | BREYANZI |
Mark Drawing Type | 3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S) |
Mark Type | TRADEMARK |
Standard Character Claim | No |
Register | PRINCIPAL |
Current Location | INTENT TO USE SECTION 2019-12-17 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Camille M. Miller |
Attorney Docket Number | 453618/CELG- |
Law Office Assigned | L40 |
Employee Name | KENEALY, NATALIE LANGF |
2019-08-07 | Application Filed |
2019-10-22 | Published |
2019-10-22 | Published for Opposition |
2019-12-17 | Location: INTENT TO USE SECTION |
2019-12-17 | Status: Live/Pending |
2019-12-17 | Transaction Date |
2021-01-22 | Status: Application revived and is awaiting further action. |
2022-08-30 | Trademark Registered |
Party: | JUNO THERAPEUTICS, INC. |
Address | 400 DEXTER AVENUENORTH SUITE 1200 SEATTLE, WASHINGTON UNITED STATES 98109 |
Legal Entity Type | Corporation |
Legal Entity State | DELAWARE |
Drawing | JPEG | 2019-08-07 |
TEAS RF New Application | MULTI | 2019-08-07 |
Design Search Code Corr Project | XML | 2019-08-24 |
Notation to File | XML | 2019-09-17 |
XSearch Search Summary | XML | 2019-09-17 |
TRAM Snapshot of App at Pub for Oppostn | APPLICATION/XML,IMAGE/JPEG | 2019-09-18 |
Notice of Publication | XML | 2019-10-02 |
Notification Of Notice of Publication | XML | 2019-10-02 |
OG Publication Confirmation | XML | 2019-10-22 |
Notice of Allowance | XML | 2019-12-17 |
Extension of Time to File SOU | XML | 2020-04-15 |
ITU Extension Approval | XML | 2020-04-17 |
ITU Unit Action | MULTI | 2020-04-17 |
ITU Unit Action | MULTI | 2021-01-19 |
Notice of Abandonment | APPLICATION/XML | 2021-01-19 |
Change Address or Representation Form | XML | 2021-01-20 |
TEAS Petition to Revive SOU | MULTI | 2021-01-21 |
Notice Of Revive Application | XML | 2021-01-22 |
26.01.11 | Circles comprised of animals; Circles comprised of geometric figures; Circles comprised of humans; Circles comprised of letters or numerals; Circles comprised of plants; Circles comprised of punctuation; Letters, numerals, punctuation, geometric figures, objects, humans, plants or animals comprising a circle |
26.01.21 | Circles that are totally or partially shaded. |
26.01.31 | Circles |
260105 | Circles made of broken or dotted lines |
260111 | Circles comprised of animals; Circles comprised of geometric figures; Circles comprised of humans; Circles comprised of letters or numerals; Circles comprised of plants; Circles comprised of punctuation; Letters, numerals, punctuation, geometric figures, objects, humans, plants or animals comprising a circle |
260121 | Circles that are totally or partially shaded. |
260131 | Circles |
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations for the treatment of cancer and auto-immune diseases; pharmaceutical preparations for the treatment of lymphoma; pharmaceutical preparations for inhibiting cytokine production; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations, namely, preparations for use in the treatment of tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy; cells for medical or clinical use; diagnostic kits consisting primarily of cells for medical or clinical use
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
CC0000 | The color(s) dark blue, light blue, and orange is/are claimed as a feature of the mark. |
DM0000 | The mark consists of "BREYANZI" in dark blue font with an orange dot over the "I" with a sunburst design behind and above the "ZI" with half of the dots in the upper side in dark blue dots and the other half of the dots in the lower side in light blue dots. |
Description | Date |
---|---|
Trademark Assignment 6778-0435 [3 Pages] | 2019-10-24 |
Description | Date | Proceeding Number |
---|---|---|
NOTICE OF REVIVAL - E-MAILED | 2021-01-22 | |
TEAS PETITION TO REVIVE RECEIVED | 2021-01-21 | |
PETITION TO REVIVE-GRANTED | 2021-01-21 | 88889 |
EXTENSION RECEIVED WITH TEAS PETITION | 2021-01-21 | |
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | 2021-01-20 | |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2021-01-20 | |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2021-01-20 | |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2021-01-20 | |
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | 2021-01-19 | |
ABANDONMENT - NO USE STATEMENT FILED | 2021-01-18 | 99999 |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-04-17 | |
TEAS EXTENSION RECEIVED | 2020-04-15 | |
EXTENSION 1 GRANTED | 2020-04-15 | 98765 |
EXTENSION 1 FILED | 2020-04-15 | 98765 |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2019-12-17 | |
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2019-10-30 | |
PUBLISHED FOR OPPOSITION | 2019-10-22 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-10-22 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-10-02 | |
ASSIGNED TO EXAMINER | 2019-09-17 | 86868 |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-09-17 | |
NOTICE OF DESIGN SEARCH CODE E-MAILED | 2019-08-24 | |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-08-23 | |
NEW APPLICATION ENTERED IN TRAM | 2019-08-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.